Logo image of XPEV

XPENG INC - ADR (XPEV) Stock Fundamental Analysis

NYSE:XPEV - New York Stock Exchange, Inc. - US98422D1054 - ADR - Currency: USD

18.2  -0.02 (-0.11%)

Premarket: 18.76 +0.56 (+3.08%)

Fundamental Rating

3

Taking everything into account, XPEV scores 3 out of 10 in our fundamental rating. XPEV was compared to 41 industry peers in the Automobiles industry. XPEV has a bad profitability rating. Also its financial health evaluation is rather negative. XPEV is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year XPEV has reported negative net income.
In the past 5 years XPEV always reported negative net income.
In the past 5 years XPEV reported 4 times negative operating cash flow.
XPEV Yearly Net Income VS EBIT VS OCF VS FCFXPEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B -8B -10B

1.2 Ratios

With a decent Return On Assets value of -7.00%, XPEV is doing good in the industry, outperforming 60.98% of the companies in the same industry.
The Return On Equity of XPEV (-18.51%) is better than 60.98% of its industry peers.
Industry RankSector Rank
ROA -7%
ROE -18.51%
ROIC N/A
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
XPEV Yearly ROA, ROE, ROICXPEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

XPEV has a Gross Margin of 16.14%. This is in the better half of the industry: XPEV outperforms 63.41% of its industry peers.
In the last couple of years the Gross Margin of XPEV has grown nicely.
XPEV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.11%
GM growth 5YN/A
XPEV Yearly Profit, Operating, Gross MarginsXPEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XPEV has more shares outstanding
The number of shares outstanding for XPEV has been increased compared to 5 years ago.
Compared to 1 year ago, XPEV has an improved debt to assets ratio.
XPEV Yearly Shares OutstandingXPEV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
XPEV Yearly Total Debt VS Total AssetsXPEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

XPEV has an Altman-Z score of 1.16. This is a bad value and indicates that XPEV is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.16, XPEV is doing good in the industry, outperforming 65.85% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that XPEV is not too dependend on debt financing.
XPEV's Debt to Equity ratio of 0.35 is fine compared to the rest of the industry. XPEV outperforms 60.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 1.16
ROIC/WACCN/A
WACC13.65%
XPEV Yearly LT Debt VS Equity VS FCFXPEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B 40B

2.3 Liquidity

XPEV has a Current Ratio of 1.25. This is a normal value and indicates that XPEV is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, XPEV perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
A Quick Ratio of 1.11 indicates that XPEV should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.11, XPEV is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.11
XPEV Yearly Current Assets VS Current LiabilitesXPEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.91% over the past year.
Looking at the last year, XPEV shows a very strong growth in Revenue. The Revenue has grown by 33.22%.
The Revenue has been growing by 77.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)48.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.28%
Revenue 1Y (TTM)33.22%
Revenue growth 3Y24.87%
Revenue growth 5Y77.48%
Sales Q2Q%23.41%

3.2 Future

Based on estimates for the next years, XPEV will show a very strong growth in Earnings Per Share. The EPS will grow by 23.29% on average per year.
Based on estimates for the next years, XPEV will show a very strong growth in Revenue. The Revenue will grow by 29.30% on average per year.
EPS Next Y62.07%
EPS Next 2Y50.11%
EPS Next 3Y35.03%
EPS Next 5Y23.29%
Revenue Next Year95.21%
Revenue Next 2Y62.59%
Revenue Next 3Y44.4%
Revenue Next 5Y29.3%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XPEV Yearly Revenue VS EstimatesXPEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50B 100B 150B
XPEV Yearly EPS VS EstimatesXPEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XPEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XPEV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XPEV Price Earnings VS Forward Price EarningsXPEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPEV Per share dataXPEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

XPEV's earnings are expected to grow with 35.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.11%
EPS Next 3Y35.03%

More info and screens

0

5. Dividend

5.1 Amount

XPEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPENG INC - ADR

NYSE:XPEV (4/21/2025, 8:04:00 PM)

Premarket: 18.76 +0.56 (+3.08%)

18.2

-0.02 (-0.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)03-18 2025-03-18/bmo
Earnings (Next)05-19 2025-05-19/bmo
Inst Owners14.49%
Inst Owner Change10.36%
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap17.30B
Analysts76.67
Price Target22.82 (25.38%)
Short Float %10.06%
Short Ratio2.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.1%
Min EPS beat(2)-8.69%
Max EPS beat(2)-1.5%
EPS beat(4)1
Avg EPS beat(4)2.61%
Min EPS beat(4)-8.69%
Max EPS beat(4)26.7%
EPS beat(8)2
Avg EPS beat(8)-2.73%
EPS beat(12)3
Avg EPS beat(12)-7.3%
EPS beat(16)5
Avg EPS beat(16)-5.73%
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)1.37%
Revenue beat(4)1
Avg Revenue beat(4)-3.63%
Min Revenue beat(4)-11.83%
Max Revenue beat(4)1.37%
Revenue beat(8)1
Avg Revenue beat(8)-5.86%
Revenue beat(12)2
Avg Revenue beat(12)-5.55%
Revenue beat(16)6
Avg Revenue beat(16)-2.27%
PT rev (1m)24.34%
PT rev (3m)55.41%
EPS NQ rev (1m)-29.86%
EPS NQ rev (3m)-3.38%
EPS NY rev (1m)17.39%
EPS NY rev (3m)21.78%
Revenue NQ rev (1m)1.72%
Revenue NQ rev (3m)4.94%
Revenue NY rev (1m)10.42%
Revenue NY rev (3m)12.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.09
P/FCF N/A
P/OCF N/A
P/B 4.04
P/tB 4.73
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.89
BVpS4.51
TBVpS3.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7%
ROE -18.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.14%
FCFM N/A
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.11%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1.11
Altman-Z 1.16
F-ScoreN/A
WACC13.65%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.28%
EPS Next Y62.07%
EPS Next 2Y50.11%
EPS Next 3Y35.03%
EPS Next 5Y23.29%
Revenue 1Y (TTM)33.22%
Revenue growth 3Y24.87%
Revenue growth 5Y77.48%
Sales Q2Q%23.41%
Revenue Next Year95.21%
Revenue Next 2Y62.59%
Revenue Next 3Y44.4%
Revenue Next 5Y29.3%
EBIT growth 1Y37.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.93%
EBIT Next 3Y38.57%
EBIT Next 5Y30.52%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A